Adempas and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adempas (riociguat) and Pulmicort (budesonide). Common drug interactions include malaise among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Adempas and Pulmicort. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Adempas?

Adempas has active ingredients of riociguat. eHealthMe is studying from 29,741 Adempas users. Check the latest studies of Adempas.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

On Aug, 04, 2026

33 people who take Adempas and Pulmicort together, and have interactions are studied.

Adempas and Pulmicort drug interactions.

What are the common drug interactions of Adempas and Pulmicort, by gender? *:

female:

Malaise (a feeling of general discomfort or uneasiness)
Nasopharyngitis (inflammation of the nasopharynx)
Pain
Pain in extremity
Pain in jaw
Peripheral swelling
Pulmonary oedema (fluid accumulation in the lungs)
Rales (an abnormal respiratory sound characterized by fine crackles)
Weight increased
White blood cell count increased

male:

Dyspnoea (difficult or laboured respiration)
Acute respiratory failure
Acute myocardial infarction (acute heart attack)
Bedridden
Death
Fluid retention (an abnormal accumulation of fluid in the blood)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Hypoxia (low oxygen in tissues)
Sepsis (a severe blood infection that can lead to organ failure and death)
Swelling

What are the common drug interactions of Adempas and Pulmicort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Hospitalisation

50-59:

Malaise (a feeling of general discomfort or uneasiness)
Nasopharyngitis (inflammation of the nasopharynx)
Rales (an abnormal respiratory sound characterized by fine crackles)
Syncope (loss of consciousness with an inability to maintain postural tone)
Sputum retention
Chest pain
Contusion (a type of hematoma of tissue in which capillaries)
Cough
Dizziness
Dysgeusia (disorder of the sense of taste)

60+:

Oxygen saturation decreased
Pleural effusion (water on the lungs)
Diarrhoea
Dyspnoea exertional (breathlessness or shortness of breath)
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Abdominal pain
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haemoglobin decreased
Vomiting

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 22 people, 66.67%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 15 people, 45.45%
Essential Hypertension (primary hypertension): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Adempas and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously